Project Grant DP2AG109047
- The National Institutes of Health Office of the Director awarded The University of Chicago $137,760 under the Trans-NIH Research Support program (CFDA 93.310) on September 1, 2026, to develop and translate statistical software tools for genomics research. The award funds development of high-quality statistical software addressing three areas where existing tools are lacking: fine-mapping of health- and disease-related quantitative trait loci (QTLs), including molecular QTLs; gene set...
- The National Institutes of Health National Center for Complementary and Integrative Health awarded The University of Chicago $1,206,896 on August 12, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) for Project Grant R01AT013753. The award funds research investigating exclusive metabolic niches as a strategy for precision microbiome manipulation. The work encompasses three aims: investigating the ecological function of exclusive metabolic...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded Northwestern University $180,975 on July 15, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to enhance Network Canvas, a free and open-source software platform for capturing social network survey data. The award funds a research software engineer to transition the Network Canvas codebase to TypeScript, resolve technical debt, enhance the protocol builder feature, support...
- The National Institute of Dental and Craniofacial Research awarded The University of Chicago $133,239 on April 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop and deliver a research education program called Cultivating Researchers in Oral and Systemic Health Studies (CROSS). The program trains undergraduate students enrolled in colleges across the Chicago area in cross-disciplinary clinical research that integrates oral health, medicine, and the social...
- The National Institute on Drug Abuse awarded The University of Chicago $1,105,220 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct the Pathways to Improved Health and Housing Study, a hybrid type 2 implementation-effectiveness research study examining bundled interventions to improve HIV, substance use, and housing outcomes among individuals with criminal legal system involvement who use substances and are living with or vulnerable to HIV. The...
- The National Institute of General Medical Sciences awarded The University of Chicago $451,000 on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop statistical methods linking genetic variants to regulatory landscapes and disease mechanisms. The award funds research to move beyond cis gene regulation toward trans regulation of genes and proteins and genetic regulation of the epigenome. Specific deliverables include comprehensively mapping...
- The National Institute of Dental and Craniofacial Research, part of the National Institutes of Health under the Department of Health and Human Services, awarded The University of Chicago $328,000 on August 5, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop and validate a microsimulation model of oral health lifetime outcomes and resource use in older adults. The project, titled "Development and Validation of the U.S. Oral Health Microsimulation...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded the University of Illinois $757,625 on September 1, 2026, under the Trans-NIH Research Support program (CFDA 93.310) for the development of multiplexed connectomic mapping methods for brain microcircuits. The funded work will develop an integrated platform combining computational design of epitope-defined affinity binders for cell-type identification, electron microscopy-compatible...
- The National Heart, Lung, and Blood Institute awarded The University of Chicago $817,976 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop single molecule footprinting methods for studying gene regulation in cardiac differentiation and disease. The recipient will combine methyltransferase-based chromatin measurement with native long-read sequencing to assess chromatin accessibility, nucleosome positioning, transcription factor binding, and DNA...
- The National Institute of General Medical Sciences awarded The University of Chicago $410,000 on March 15, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop computational methods enhancing causal inference in genetics and genomics over a five-year period through December 31, 2030. The research addresses confounding and generalizability barriers in Mendelian randomization and single-cell CRISPR screening by creating statistical and machine learning tools...
The National Institutes of Health Office of the Director awarded The University of Chicago $779,000 on September 15, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to investigate the financial, operational, and quality impacts of management consultants on nonprofit health care delivery organizations in the United States. The project applies modern empirical methods to evaluate consultant costs and effects by leveraging IRS Form 990 tax filings for nonprofit health care organizations, machine learning to identify consulting contracts, and causal inference techniques linked to organizational- and patient-level datasets. The research addresses three core questions: total consulting spending across nonprofit health care delivery organizations; the major types of organizations using consultants and the types of consultants engaged; and the causal impacts of consulting engagement on financial performance, operational efficiency, and quality of care. Findings will inform policies governing consulting contracts, financial transparency, nonprofit accountability, and health care waste reduction. Performance takes place in Chicago, Illinois, with a period of performance extending from September 15, 2026, through June 30, 2031. The award is structured as a Project Grant, subject to NIH audit requirements under OMB 2 CFR 200.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $779.0k | 8/31/26 |